CytoMed Therapeutics Limited Ordinary Shares (GDTC) is a publicly traded Healthcare sector company. As of July 24, 2026, GDTC trades at $1.00 with a market cap of $10.41M and a P/E ratio of 0.00. GDTC moved +13.64% today. Year to date, GDTC is -37.59%; over the trailing twelve months it is -56.44%. Its 52-week range spans $0.68 to $4.05. Rallies surfaces GDTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GDTC insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $10.41M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.05 |
| 52-Week Low | $0.68 |
| Volume | 22.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
GDTC analyst coverage data. Average price target: $0.00.